Skip to main content
Premium Trial:

Request an Annual Quote

Tripos Shares Jump 7.14 Percent After French Drug Maker Taps Company for Discovery Deal

NEW YORK, Aug. 30 (GenomeWeb News) - Shares in Tripos were up 7.14 percent, or $.29, at $4.35 in mid-afternoon trading today after the company said it will work with a French drug maker to identigy potential drug targets.


Terms of the deal call for Servier to use Tripos' ChemSpace and LeadHopping technology and its chemistry processes to identify chemistries against targets that it had previously uncovered using Tripos' LeadQuest compound collection, the companies said.


Financial terms of the agreement were not disclosed.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.